SCPH (scPharmaceuticals, Inc.) Bozor qiymatining balans qiymatiga nisbati
Ushbu grafik qulay uy sharoitida infuziya usullarini taklif qiluvchi, yurak yetishmovchiligi terapiyasi bo'yicha tan olingan innovator scPharmaceuticals Inc. (SCPH) aksiyalarini ko'rsatadi. Nasos va eritma ishlab chiqarishning barqarorligi hamkorlarning funksional uskunalari va qat'iy sterillik nazorati bilan ta'minlanadi. Joriy ko'rsatkich -14.12 darajasida turibdi, biznesning o'sishi esa sug'urta kompaniyalari tomonidan tan olinishiga va tizimlarning shifoxona tashqarisida foydalanish imkoniyatiga bog'liq.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_SCPH_-_scPharmaceuticals-Inc._-_Market-Capitalization-to-Net-Assets "SCPH scPharmaceuticals Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 18.10.2025) | 👁️GURU.Markets👁️")
scPharmaceuticals Inc. (SCPH) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati scPharmaceuticals Inc.|SCPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati scpharmaceuticals.com|SCPH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar scPharma|SCPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari scPharmaceuticals
Kompaniyaning dastlabki tahlili:scPharmaceuticals, Inc. - SCPH
scPharmaceuticals Inc. (SCPH) kompaniyasida infuzion tizimlar ishlab chiqarishda ESG standartlarining joriy etilishi resurslarni boshqarish samaradorligini oshiradi, bu esa sof aktivlar qiymatiga bevosita ta'sir qiladi. Kompaniyaning P/B koeffitsiyenti tahlili joriy bozor narxi va balans qiymatini solishtirish imkonini beradi, bu esa haqiqiy biznes diskontini ochib beradi va investorlarga bozor tebranishlari davrida qadrsizlangan aktivni qiymat tuzog'idan ajratishga yordam beradi.
Asosiy raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati Haleon plc HLN|KVUE (kenvue.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati ABVC|Balans qiymatiga nisbatan bozor kapitallashuvi Cumberland Pharmaceuticals Inc CPIX|QNTM: Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals (TELO)|Rani Therapeutics Holdings, Inc. (RANI) - Sof aktivlarga nisbatan bozor kapitallashuvi|SNYR - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Rallybio Corp.|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati PULM (Pulmatrix Corporation)|Bozor qiymatining balans qiymatiga nisbati Pheton Holdings|Aptorum Group Ltd - Balans qiymatiga nisbatan bozor qiymati|LYRA: Bozor qiymatining balans qiymatiga nisbati|IBO - Kapitallashuvning sof aktivlarga nisbati|TNFA: Bozor kapitallashuvining balans qiymatiga nisbati|cbdMD (YCBD) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PRFX|Kapitallashuvning sof aktivlarga nisbati Auris Medical|Lipella Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OptiNose Inc OPTN|Kapitallashuvning sof aktivlarga nisbati PIRS (Pieris)|PROC - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Petros Pharmaceuticals PTPI|QLI - Bozor kapitallashuvining balans qiymatiga multiplikatori|ACELYRIN - Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor kapitallashuvi